NPORT-EX 2 70A6TRPBlueChipGrowth.htm
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
March
31,
2021
(Unaudited)
1
Portfolio
of
Investments
‡
Shares
$
Value
(Cost
and
value
in
$000s)
‡
COMMON
STOCKS
99.8%
COMMUNICATION
SERVICES
25.1%
Entertainment
5.2%
Live
Nation
Entertainment (1)
461,200‌
39,040‌
Netflix (1)
4,523,413‌
2,359,684‌
Roku (1)
365,229‌
118,981‌
Sea,
ADR (1)
6,907,708‌
1,542,008‌
Spotify
Technology (1)
2,094,646‌
561,260‌
Walt
Disney (1)
1,587,705‌
292,963‌
4,913,936‌
Interactive
Media
&
Services
19.7%
Alphabet,
Class
A (1)
633,826‌
1,307,279‌
Alphabet,
Class
C (1)
2,837,143‌
5,868,999‌
Facebook,
Class
A (1)
21,804,889‌
6,422,194‌
IAC/InterActiveCorp (1)
215,300‌
46,572‌
Kuaishou
Technology
(HKD) (1)
1,054,600‌
36,627‌
Match
Group (1)
6,034,301‌
828,992‌
Pinterest,
Class
A (1)
3,928,448‌
290,823‌
Snap,
Class
A (1)
21,624,965‌
1,130,769‌
Tencent
Holdings
(HKD) 
33,241,000‌
2,652,883‌
18,585,138‌
Media
0.0%
Charter
Communications,
Class
A (1)
32,024‌
19,759‌
19,759‌
Wireless
Telecommunication
Services
0.2%
T-Mobile
US (1)
1,219,343‌
152,771‌
152,771‌
Total
Communication
Services
23,671,604‌
CONSUMER
DISCRETIONARY
19.9%
Auto
Components
0.2%
Aptiv
 (1)
1,017,509‌
140,315‌
140,315‌
Hotels,
Restaurants
&
Leisure
2.1%
Booking
Holdings (1)
339,903‌
791,920‌
Chipotle
Mexican
Grill (1)
468,790‌
666,066‌
Hilton
Worldwide
Holdings (1)
450,523‌
54,477‌
Marriott
International,
Class
A (1)
75,502‌
11,183‌
McDonald's 
76,025‌
17,040‌
Starbucks 
1,716,534‌
187,566‌
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
2
Shares
$
Value
(Cost
and
value
in
$000s)
Yum!
Brands 
2,312,407‌
250,156‌
1,978,408‌
Internet
&
Direct
Marketing
Retail
14.1%
Alibaba
Group
Holding,
ADR (1)
10,434,632‌
2,365,844‌
Amazon.com (1)
3,288,677‌
10,175,430‌
Coupang
 (1)(2)
2,421,612‌
119,507‌
DoorDash
,
Class
A (1)
345,041‌
45,245‌
Etsy (1)
1,284,325‌
259,010‌
JD.com,
ADR (1)
1,960,652‌
165,342‌
Pinduoduo
,
ADR (1)
1,191,234‌
159,482‌
13,289,860‌
Multiline
Retail
0.8%
Dollar
General 
3,870,574‌
784,256‌
Dollar
Tree (1)
102,700‌
11,755‌
796,011‌
Specialty
Retail
1.2%
Carvana
 (1)
1,488,422‌
390,562‌
Ross
Stores 
5,085,920‌
609,853‌
TJX 
2,073,045‌
137,132‌
1,137,547‌
Textiles,
Apparel
&
Luxury
Goods
1.5%
Lululemon
Athletica
 (1)
1,933,842‌
593,129‌
NIKE,
Class
B 
5,451,676‌
724,473‌
VF 
883,436‌
70,604‌
1,388,206‌
Total
Consumer
Discretionary
18,730,347‌
CONSUMER
STAPLES
0.0%
Personal
Products
0.0%
Estee
Lauder,
Class
A 
135,497‌
39,409‌
Total
Consumer
Staples
39,409‌
FINANCIALS
3.2%
Capital
Markets
2
.9%
Charles
Schwab 
7,152,308‌
466,187‌
Goldman
Sachs
Group 
3,441,455‌
1,125,356‌
Intercontinental
Exchange 
3,121,922‌
348,656‌
Morgan
Stanley 
425,508‌
33,045‌
MSCI 
231,495‌
97,061‌
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
3
Shares
$
Value
(Cost
and
value
in
$000s)
S&P
Global 
1,907,259‌
673,015‌
2,743,320‌
Insurance
0.3%
Chubb 
1,369,192‌
216,291‌
Marsh
&
McLennan 
519,023‌
63,217‌
Willis
Towers
Watson 
136,368‌
31,212‌
310,720‌
Total
Financials
3,054,040‌
HEALTH
CARE
11.8%
Biotechnology
0.9%
AbbVie 
792,415‌
85,755‌
Exact
Sciences (1)
39,004‌
5,140‌
Incyte
 (1)
2,660,710‌
216,236‌
Vertex
Pharmaceuticals (1)
2,637,542‌
566,781‌
873,912‌
Health
Care
Equipment
&
Supplies
3.9%
Abbott
Laboratories 
1,013,248‌
121,428‌
Align
Technology (1)
231,023‌
125,106‌
Becton
Dickinson
&
Company 
116,829‌
28,407‌
Danaher 
4,010,549‌
902,694‌
DENTSPLY
SIRONA 
2,733,473‌
174,423‌
Intuitive
Surgical (1)
1,577,074‌
1,165,363‌
Stryker 
4,862,843‌
1,184,491‌
3,701,912‌
Health
Care
Providers
&
Services
5.2%
Anthem 
1,468,843‌
527,241‌
Centene
 (1)
6,536,568‌
417,752‌
Cigna 
4,854,556‌
1,173,540‌
HCA
Healthcare 
3,502,700‌
659,699‌
Humana 
624,090‌
261,650‌
UnitedHealth
Group 
4,949,828‌
1,841,682‌
4,881,564‌
Health
Care
Technology
0.2%
Veeva
Systems,
Class
A (1)
896,903‌
234,307‌
234,307‌
Life
Sciences
Tools
&
Services
0.8%
PPD (1)
2,554,485‌
96,662‌
Thermo
Fisher
Scientific 
1,491,577‌
680,726‌
777,388‌
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
4
Shares
$
Value
(Cost
and
value
in
$000s)
Pharmaceuticals
0.8%
AstraZeneca,
ADR (2)
2,648,900‌
131,703‌
Eli
Lilly
and
Company 
927,932‌
173,356‌
Zoetis 
2,898,885‌
456,517‌
761,576‌
Total
Health
Care
11,230,659‌
INDUSTRIALS
&
BUSINESS
SERVICES
2.4%
Airlines
0.0%
United
Airlines
Holdings (1)
267,810‌
15,410‌
15,410‌
Commercial
Services
&
Supplies
0.2%
Cintas 
635,408‌
216,871‌
Copart
 (1)
87,295‌
9,481‌
226,352‌
Electrical
Equipment
0.1%
Generac
Holdings (1)
153,700‌
50,329‌
50,329‌
Industrial
Conglomerates
0.8%
General
Electric 
21,461,287‌
281,787‌
Honeywell
International 
224,448‌
48,721‌
Roper
Technologies 
975,430‌
393,430‌
723,938‌
Machinery
0.3%
Fortive
3,043,306‌
214,979‌
Parker-Hannifin 
63,014‌
19,877‌
234,856‌
Professional
Services
0.6%
CoStar
Group (1)
574,878‌
472,486‌
Equifax 
501,131‌
90,770‌
563,256‌
Road
&
Rail
0.4%
Kansas
City
Southern 
190,852‌
50,370‌
Norfolk
Southern 
908,903‌
244,058‌
Union
Pacific 
524,518‌
115,609‌
410,037‌
Total
Industrials
&
Business
Services
2,224,178‌
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
5
Shares
$
Value
(Cost
and
value
in
$000s)
INFORMATION
TECHNOLOGY
36.7%
Electronic
Equipment,
Instruments
&
Components
0.2%
TE
Connectivity 
1,719,601‌
222,018‌
222,018‌
IT
Services
13.1%
ANT
International,
Class
C,
Acquisition
Date:
6/7/18,
Cost
$104,885 (1)(3)(4)
18,696,173‌
150,878‌
Automatic
Data
Processing 
530,595‌
100,001‌
Fidelity
National
Information
Services 
3,460,555‌
486,589‌
Fiserv (1)
9,137,768‌
1,087,760‌
Global
Payments 
9,814,602‌
1,978,427‌
Mastercard
,
Class
A 
6,209,797‌
2,210,998‌
MongoDB (1)
195,092‌
52,173‌
PayPal
Holdings (1)
9,976,711‌
2,422,745‌
Shopify,
Class
A (1)
410,856‌
454,612‌
Snowflake,
Class
A (1)
67,582‌
15,495‌
Square,
Class
A (1)
256,163‌
58,162‌
Twilio
,
Class
A (1)
456,247‌
155,471‌
Visa,
Class
A 
13,709,777‌
2,902,771‌
Wix.com (1)
989,240‌
276,216‌
12,352,298‌
Semiconductors
&
Semiconductor
Equipment
3.7%
Advanced
Micro
Devices (1)
7,971,168‌
625,737‌
Applied
Materials 
1,013,177‌
135,360‌
ASML
Holding 
122,800‌
75,812‌
Marvell
Technology
Group 
11,487,233‌
562,645‌
Maxim
Integrated
Products 
2,666,283‌
243,618‌
Microchip
Technology 
923,600‌
143,361‌
Monolithic
Power
Systems 
269,754‌
95,280‌
NVIDIA 
2,098,503‌
1,120,454‌
QUALCOMM 
60,828‌
8,065‌
Taiwan
Semiconductor
Manufacturing,
ADR 
245,800‌
29,073‌
Texas
Instruments 
2,410,689‌
455,596‌
3,495,001‌
Software
14.8%
Atlassian
,
Class
A (1)
993,511‌
209,392‌
Coupa
Software (1)
891,565‌
226,885‌
Crowdstrike
Holdings,
Class
A (1)
697,615‌
127,322‌
DocuSign (1)
796,381‌
161,227‌
Fortinet (1)
884,400‌
163,101‌
Intuit 
5,589,287‌
2,141,032‌
Microsoft 
21,943,852‌
5,173,702‌
Paycom
Software (1)
282,694‌
104,614‌
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
6
Shares
$
Value
(Cost
and
value
in
$000s)
salesforce.com (1)
7,638,834‌
1,618,440‌
ServiceNow
 (1)
4,378,045‌
2,189,504‌
Splunk
 (1)
3,101,525‌
420,195‌
Synopsys (1)
2,985,696‌
739,796‌
Workday,
Class
A (1)
1,375,617‌
341,745‌
Zoom
Video
Communications,
Class
A (1)
1,166,443‌
374,766‌
13,991,721‌
Technology
Hardware,
Storage
&
Peripherals
4.9%
Apple 
37,686,284‌
4,603,380‌
4,603,380‌
Total
Information
Technology
34,664,418‌
MATERIALS
0.7%
Chemicals
0.5%
Linde 
1,101,971‌
308,706‌
Sherwin-Williams 
158,662‌
117,094‌
425,800‌
Containers
&
Packaging
0.2%
Avery
Dennison 
884,000‌
162,347‌
162,347‌
Total
Materials
588,147‌
Total
Common
Stocks
(Cost
$40,517,791)
94,202,802‌
CONVERTIBLE
PREFERRED
STOCKS
0.3%
CONSUMER
DISCRETIONARY
0.3%
Automobiles
0.3%
Rivian
Automotive,
Series
F,
Acquisition
Date:
1/19/21,
Cost
$225,639 (1)(3)(4)
6,123,173‌
225,639‌
Total
Consumer
Discretionary
225,639‌
INFORMATION
TECHNOLOGY
0.0%
Software
0.0%
Databricks
,
Series
G,
Acquisition
Date:
2/1/21,
Cost
$31,087 (1)
(3)(4)
175,270‌
31,087‌
Total
Information
Technology
31,087‌
Total
Convertible
Preferred
Stocks
(Cost
$256,726)
256,726‌
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
7
Shares
$
Value
(Cost
and
value
in
$000s)
SHORT-TERM
INVESTMENTS
0.2%
Money
Market
Funds
0.2%
T.
Rowe
Price
Government
Reserve
Fund,
0.04% (5)(6)
191,179,425‌
191,179‌
Total
Short-Term
Investments
(Cost
$191,179)
191,179‌
SECURITIES
LENDING
COLLATERAL
0.1%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
STATE
STREET
BANK
AND
TRUST
COMPANY
0.1%
Short-Term
Funds
0.1%
T.
Rowe
Price
Short-Term
Fund,
0.08% (5)(6)
10,853,860‌
108,539‌
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
State
Street
Bank
and
Trust
Company
108,539‌
Total
Securities
Lending
Collateral
(Cost
$108,539)
108,539‌
Total
Investments
in
Securities
100.4%
(Cost
$41,074,235)
$
94,759,246‌
Other
Assets
Less
Liabilities
(0.4)%
(391,192‌)
Net
Assets
100.0%
$
94,368,054‌
‡
Shares
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
(1)
Non-income
producing
(2)
All
or
a
portion
of
this
security
is
on
loan
at
March
31,
2021.
(3)
Level
3
in
fair
value
hierarchy.
(4)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
has
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$407,604
and
represents
0.4%
of
net
assets.
(5)
Seven-day
yield
(6)
Affiliated
Companies
ADR
American
Depositary
Receipts
HKD
Hong
Kong
Dollar
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
8
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
three
months
ended
March
31,
2021.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
0.04%
$
—‌
$
—‌
$
36‌
T.
Rowe
Price
Short-Term
Fund,
0.08%
—‌
—‌
—‌++
Totals
$
—‌#
$
—‌
$
36‌+
`0.00
`0.00
`0.00
Supplementary
Investment
Schedule
Affiliate
Value
12/31/20
Purchase
Cost
Sales
Cost
Value
03/31/21
T.
Rowe
Price
Government
Reserve
Fund,
0.04%
$
345,440‌
 ¤
 ¤
$
191,179‌
T.
Rowe
Price
Short-Term
Fund,
0.08%
317,930‌
 ¤
 ¤
108,539‌
Total
$
299,718‌^
#
Capital
gain
distributions
from
mutual
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees.
+
Investment
income
comprised
$36
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$299,718.
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
Unaudited
Notes
to
Portfolio
of
Investments
9
T.
Rowe
Price
Blue
Chip
Growth
Fund,
Inc. (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as
an
open-end
management
investment
company
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus. 
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The
T.
Rowe
Price
Valuation
Committee
(the
Valuation
Committee)
is
an
internal
committee
that
has
been
delegated
certain
responsibilities
by
the
fund’s
Board
of
Directors
(the
Board)
to
ensure
that
financial
instruments
are
appropriately
priced
at
fair
value
in
accordance
with
GAAP
and
the
1940
Act.
Subject
to
oversight
by
the
Board,
the
Valuation
Committee
develops
and
oversees
pricing-related
policies
and
procedures
and
approves
all
fair
value
determinations.
Specifically,
the
Valuation
Committee
establishes
policies
and
procedures
used
in
valuing
financial
instruments,
including
those
which
cannot
be
valued
in
accordance
with
normal
procedures
or
using
pricing
vendors;
determines
pricing
techniques,
sources,
and
persons
eligible
to
effect
fair
value
pricing
actions;
evaluates
the
services
and
performance
of
the
pricing
vendors;
oversees
the
pricing
process
to
ensure
policies
and
procedures
are
being
followed;
and
provides
guidance
on
internal
controls
and
valuation-related
matters.
The
Valuation
Committee
provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
10
Level
2
–
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
–
unobservable
inputs
(including
the
fund's
own
assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the
fund
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
its
portfolio
securities.
Each
business
day,
the
fund
uses
information
from
outside
pricing
services
to
evaluate
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value,
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The
fund
uses
outside
pricing
services
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
11
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The
fund
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Investments
for
which
market
quotations
or
market-based
valuations
are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Committee,
in
accordance
with
fair
valuation
policies
and
procedures.
The
objective
of
any
fair
value
pricing
determination
is
to
arrive
at
a
price
that
could
reasonably
be
expected
from
a
current
sale.
Financial
instruments
fair
valued
by
the
Valuation
Committee
are
primarily
private
placements,
restricted
securities,
warrants,
rights,
and
other
securities
that
are
not
publicly
traded.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Committee
typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Committee
may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis
and
updated
as
information
becomes
available,
including
actual
purchase
and
sale
transactions
of
the
investment.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions,
and
fair
value
prices
determined
by
the
Valuation
Committee
could
differ
from
those
of
other
market
participants.
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
12
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
March
31,
2021
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
F93-054Q1
03/21 
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
91,362,414‌
$
2,689,510‌
$
150,878‌
$
94,202,802‌
Convertible
Preferred
Stocks
—‌
—‌
256,726‌
256,726‌
Short-Term
Investments
191,179‌
—‌
—‌
191,179‌
Securities
Lending
Collateral
108,539‌
—‌
—‌
108,539‌
Total
$
91,662,132‌
$
2,689,510‌
$
407,604‌
$
94,759,246‌